WESPAC Advisors LLC lessened its stake in UnitedHealth Group Inc (NYSE:UNH) by 14.6% during the second quarter, Holdings Channel reports. The firm owned 1,358 shares of the healthcare conglomerate’s stock after selling 232 shares during the period. WESPAC Advisors LLC’s holdings in UnitedHealth Group were worth $331,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Arden Trust Co acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at $6,817,000. Nippon Life Global Investors Americas Inc. lifted its holdings in shares of UnitedHealth Group by 0.6% during the 2nd quarter. Nippon Life Global Investors Americas Inc. now owns 63,600 shares of the healthcare conglomerate’s stock valued at $15,519,000 after acquiring an additional 400 shares in the last quarter. Commerzbank Aktiengesellschaft FI lifted its holdings in shares of UnitedHealth Group by 8.1% during the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 84,909 shares of the healthcare conglomerate’s stock valued at $20,719,000 after acquiring an additional 6,385 shares in the last quarter. NewFocus Financial Group LLC lifted its holdings in shares of UnitedHealth Group by 6.5% during the 2nd quarter. NewFocus Financial Group LLC now owns 33,850 shares of the healthcare conglomerate’s stock valued at $8,260,000 after acquiring an additional 2,073 shares in the last quarter. Finally, Parsec Financial Management Inc. lifted its holdings in shares of UnitedHealth Group by 242.2% during the 2nd quarter. Parsec Financial Management Inc. now owns 25,811 shares of the healthcare conglomerate’s stock valued at $6,298,000 after acquiring an additional 18,269 shares in the last quarter. Institutional investors own 85.87% of the company’s stock.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total value of $2,419,900.00. Following the transaction, the director now owns 187,663 shares in the company, valued at approximately $45,412,569.37. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the transaction, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. Insiders sold a total of 37,000 shares of company stock worth $9,158,720 in the last quarter. 0.87% of the stock is currently owned by company insiders.
UNH stock traded up $0.80 during trading on Friday, reaching $250.05. The stock had a trading volume of 2,677,617 shares, compared to its average volume of 3,599,961. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $287.94. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.73. The firm has a market capitalization of $236.64 billion, a P/E ratio of 17.76, a P/E/G ratio of 1.33 and a beta of 0.61. The company has a fifty day moving average of $251.52.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. During the same quarter in the previous year, the business posted $3.14 EPS. The firm’s revenue was up 8.0% compared to the same quarter last year. On average, research analysts expect that UnitedHealth Group Inc will post 14.82 EPS for the current fiscal year.
Several equities analysts recently weighed in on UNH shares. ValuEngine lowered shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, April 18th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price on the stock in a report on Monday, July 22nd. SunTrust Banks reduced their target price on shares of UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a report on Wednesday, April 17th. They noted that the move was a valuation call. Oppenheimer set a $312.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Finally, Bank of America restated a “buy” rating and set a $290.00 target price (down previously from $320.00) on shares of UnitedHealth Group in a report on Wednesday, April 17th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have given a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $295.06.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: How is the Producer Price Index calculated?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.